BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9221054)

  • 41. [Insulin resistance treatments in the future].
    Philippe J; Jornayvaz F
    J Soc Biol; 2007; 201(2):155-8. PubMed ID: 17978748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going.
    DeFronzo RA
    Am J Med; 2010 Mar; 123(3 Suppl):S38-48. PubMed ID: 20206731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type 2 diabetes mellitus in childhood: obesity and insulin resistance.
    Schwartz MS; Chadha A
    J Am Osteopath Assoc; 2008 Sep; 108(9):518-24. PubMed ID: 18806081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Approaches to the management of postprandial hyperglycaemia.
    Landgraf R
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S128-32. PubMed ID: 10522837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Which treatment can be proposed to a diabetic patient presenting with secondary failure of oral antidiabetics?].
    Blanc MH; Galtier-Dereure F; Parer-Richard C; Bringer J; Jaffiol C
    Rev Med Suisse Romande; 1993 Nov; 113(11):955-61. PubMed ID: 8272722
    [No Abstract]   [Full Text] [Related]  

  • 46. Failure of insulin treatment in obese patients with non-insulin-dependent diabetes mellitus.
    Fassberg J; Toffler WL; Fields SA; Loriaux LD
    J Fam Pract; 1993 Jul; 37(1):76-81. PubMed ID: 8345343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diabetes, sport and exercise].
    Fischer H
    Clin Res Cardiol Suppl; 2011 May; 6():6-9. PubMed ID: 22528172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
    Rosenberg DE; Jabbour SA; Goldstein BJ
    Diabetes Obes Metab; 2005 Nov; 7(6):642-53. PubMed ID: 16219008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Phenotypic characteristics and insulin secretion in 25 cases of non-insulin-dependent diabetes mellitus, subtype MODY (maturity onset diabetes in the young people)].
    Muñoz S; Durruty P; García de los Ríos M
    Rev Med Chil; 1987 May; 115(5):397-403. PubMed ID: 3329377
    [No Abstract]   [Full Text] [Related]  

  • 50. [Diabetes treatment with the aim of blood glucose normalization].
    Hoizumi M; Yamada Y
    Nihon Rinsho; 2012 Aug; 70(8):1445-50. PubMed ID: 22894087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of type 2 diabetes mellitus.
    Florence JA; Yeager BF
    Am Fam Physician; 1999 May; 59(10):2835-44, 2849-50. PubMed ID: 10348076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Latest research and development trends in non-insulin anti-diabetics.
    Cheon HG
    Arch Pharm Res; 2013 Feb; 36(2):145-53. PubMed ID: 23397318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Recommendations from an expert group: treatment of non-insulin-dependent diabetes mellitus].
    Lakartidningen; 1990 Mar; 87(11):865-9. PubMed ID: 2179656
    [No Abstract]   [Full Text] [Related]  

  • 54. [Natural and preformed physical factors in the treatment of late complications in diabetes mellitus type 2].
    Topuria DI
    Vopr Kurortol Fizioter Lech Fiz Kult; 2004; (5):20-2. PubMed ID: 15575532
    [No Abstract]   [Full Text] [Related]  

  • 55. Non-insulin-dependent diabetes mellitus.
    Blackard WG
    Curr Ther Endocrinol Metab; 1994; 5():395-9. PubMed ID: 7704761
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
    Wolffenbuttel BH; van Haeften TW
    Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes.
    Schofield CJ; Sutherland C
    Diabet Med; 2012 Aug; 29(8):972-9. PubMed ID: 22443306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of Aerobic Exercise Combined with Panaxatriol Derived from Ginseng on Insulin Resistance and Skeletal Muscle Mass in Type 2 Diabetic Mice.
    Takamura Y; Nomura M; Uchiyama A; Fujita S
    J Nutr Sci Vitaminol (Tokyo); 2017; 63(5):339-348. PubMed ID: 29225319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes Mellitus Review.
    Blair M
    Urol Nurs; 2016; 36(1):27-36. PubMed ID: 27093761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current views on the mechanism of action of thiazolidinedione insulin sensitizers.
    Goldstein BJ
    Diabetes Technol Ther; 1999; 1(3):267-75. PubMed ID: 11475273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.